Ceftaroline: An Alternative Broad Spectrum Antibiotic for Pediatric Infections

Marcia L. Buck, PharmD, FCCP, FPPAG, BCPPS

Disclosures

Pediatr Pharm. 2017;23(6) 

In This Article

Summary

Several pre-approval and post-marketing studies have been published in the past 3 years demonstrating the safety and efficacy of ceftaroline in infants, children, and adolescents. These studies are useful in defining the role of this broad spectrum antibiotic in treating bacterial pneumonia and skin and skin structure infections, but additional studies are needed to evaluate its use in other infections, such as osteomyelitis. Continued monitoring will also be necessary to identify developing resistance patterns. At this time, ceftaroline is best reserved for infections that have proven refractory to standard therapies.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....